Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Stomach Adenocarcinoma × spartalizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 9 Locally Advanced Rectal Cancer 7 Neoplasm Metastasis 6 Nasopharyngeal Carcinoma 6 Colorectal Neoplasms 6 Carcinoma, Hepatocellular 6 Stomach Neoplasms 5 Rectal Neoplasms 5 Melanoma 5 Lymphoma, Extranodal NK-T-Cell 5 Triple Negative Breast Neoplasms 4 Pancreatic Neoplasms 4 Carcinoma, Renal Cell 4 Squamous Cell Carcinoma of Head and Neck 3 Sarcoma 3 Small Cell Lung Carcinoma 2 Nasopharyngeal Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Kidney Neoplasms 2 Hemangiosarcoma 2 Gastrointestinal Stromal Tumors 2 Esophageal Neoplasms 2 Cholangiocarcinoma 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Turcot syndrome 1 Thyroid cancer, follicular 1 Thyroid cancer, Hurthle cell 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1

Interventions

spartalizumab 1 Drug Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06728657 2025-06-18

TORCH-G

Fudan University

Phase 2 Suspended

Gastrointestinal

Stomach Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡